EValuate Diagnostics, Inc.

About

EValuate Diagnostics, the first spin-out company from the Hackensack Meridian Health Research Institute and its Office of Innovation and Commercialization, will market a new platform for the targeted capture of circulating biomarkers, known as extracellular vesicles. Diagnostic assays derived from this technology will help monitor disease biomarkers for earlier-than-ever detection of tumors and a wide range of other diseases.